SEM:NYSESelect Medical Holdings Corporation Analysis
Data as of 2026-08-31 - not real-time
$205.05
Latest Price
9/10Risk
Risk Level: High
Executive Summary
The moving-average structure behind Tower Semiconductor Ltd. is neutral at $205.05, with no clear ordering between short and long averages. It has lost 9.8% over the past 30 days. Relative strength is 40.1 — neutral — and the MACD signal is bearish. Watch $202.61 as support and $277.88 as the nearer resistance level.
The shares look overvalued, trading on 80.7 times earnings above a sector average of 35.8. The average analyst target implies 56.7% above today's level. Revenue is growing at 23.7% on a 16.9% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 101.8%, a beta of 2.93 and a maximum drawdown of 40.7%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 1 out of 10.
The shares look overvalued, trading on 80.7 times earnings above a sector average of 35.8. The average analyst target implies 56.7% above today's level. Revenue is growing at 23.7% on a 16.9% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 101.8%, a beta of 2.93 and a maximum drawdown of 40.7%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 1 out of 10.
Top Market Events
Seeking Alpha27dTower Semiconductor Ltd. TSEM Q2 2026 Earnings Call TranscriptGood day, and thank you for standing by....Detailed price information for Tower Semiconductor TSEM-Q from The Globe and Mail including charting and trades.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 1/10
Key Factors
- Trading above the 200-day average of 183.96
- MACD momentum is negative
- 30-day price change of -9.8%
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- P/E of 80.7 versus sector average of 35.8
- Trading above the 200-day average of 183.96
- Analyst targets imply +56.7% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 1/10
Key Factors
- P/E of 80.7 versus sector average of 35.8
- Analyst targets imply +56.7% versus the current price
- Profit margin of 16.9% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth23.70%
Profit Margin16.94%
P/E Ratio80.7
ROE9.98%
ROA4.95%
Debt/Equity4.61
P/B Ratio7.5
Op. Cash Flow$865.9M
Free Cash Flow$166.8M
Industry P/E35.8
Technical Analysis
TrendNeutral
RSI40.1
Support$202.61
Resistance$277.88
MA 20$233.19
MA 50$236.92
MA 200$183.96
MACDBearish
VolumeDecreasing
Fear & Greed Index94.79
Valuation
Fair Value$60.67
Target Price$321.32
Upside/Downside56.70%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta2.93
Volatility101.81%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.